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Abstract
Background: Syndecans regulate cell migration thus having key roles in scarring and wound healing processes.
Our previous results have shown that Thy-1/CD90 can engage both αvβ3 integrin and Syndecan-4 expressed on
the surface of astrocytes to induce cell migration. Despite a well-described role of Syndecan-4 during cell
movement, information is scarce regarding specific Syndecan-4 partners involved in Thy-1/CD90-stimulated cell
migration.
Methods: Mass spectrometry (MS) analysis of complexes precipitated with the Syndecan-4 cytoplasmic tail peptide
was used to identify potential Syndecan-4-binding partners. The interactions found by MS were validated by
immunoprecipitation and proximity ligation assays. The conducted research employed an array of genetic,
biochemical and pharmacological approaches, including: PAR-3, Syndecan-4 and Tiam1 silencing, active Rac1 GEFs
affinity precipitation, and video microscopy.
Results: We identified PAR-3 as a Syndecan-4-binding protein. Its interaction depended on the carboxy-terminal
EFYA sequence present on Syndecan-4. In astrocytes where PAR-3 expression was reduced, Thy-1-induced cell
migration and focal adhesion disassembly was impaired. This effect was associated with a sustained Focal Adhesion
Kinase activation in the siRNA-PAR-3 treated cells. Our data also show that Thy-1/CD90 activates Tiam1, a PAR-3
effector. Additionally, we found that after Syndecan-4 silencing, Tiam1 activation was decreased and it was no
longer recruited to the membrane. Syndecan-4/PAR-3 interaction and the alteration in focal adhesion dynamics
were validated in mouse embryonic fibroblast (MEF) cells, thereby identifying this novel Syndecan-4/PAR-3 signaling
complex as a general mechanism for mesenchymal cell migration involved in Thy-1/CD90 stimulation.
Conclusions: The newly identified Syndecan-4/PAR-3 signaling complex participates in Thy-1/CD90-induced focal
adhesion disassembly in mesenchymal cells. The mechanism involves focal adhesion kinase dephosphorylation and
Tiam1 activation downstream of Syndecan-4/PAR-3 signaling complex formation. Additionally, PAR-3 is defined here
as a novel adhesome-associated component with an essential role in focal adhesion disassembly during polarized
cell migration. These novel findings uncover signaling mechanisms regulating cell migration, thereby opening up
new avenues for future research on Syndecan-4/PAR-3 signaling in processes such as wound healing and scarring.
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Plain English summary
Cell movement is crucial during wound healing and scar-
ing processes. To move, cells need to coordinately pro-
trude and form points of adhesion (or focal adhesions)
with the surrounding matrix (substrate) at one end of
their body (head) and disassemble these focal adhesions
on the opposite side (tail). Then, small fibers located in
the cell body can pull the tail of the cell towards the head,
to move the cell forward, in a repetitive process of protru-
sion–adhesion–contraction–detachment. Different pro-
teins present on the cell surface regulate cell movement
by coordinating adhesion of the cells to the substrate. Our
previous studies show that Thy-1/CD90, a protein found
in neurons, activated endothelium and some fibroblasts,
regulates cell movement through its interaction with two
other membrane proteins: integrin and Syndecan-4. Here,
we describe the mechanism by which Thy-1/CD90 con-
trols such movement, by unveiling a novel interaction be-
tween Syndecan-4 and PAR-3, a protein that has been
involved in cell polarity. When this interaction was
blocked, for example after decreasing the amount of PAR-
3 or Syndecan-4, we found that cells did not move, be-
cause they were not capable of disassembling those points
of contact with the substrate, thus impeding the cyclic
process of cell motility.
Background
Focal adhesion (FA), a key type of adhesive cell and
extracellular matrix contact, is relevant for both mech-
anical and biochemical signaling [1]. The binding of
transmembrane proteins (e.g., integrins and Syndecan-4)
to extracellular ligands and the cytoskeleton mediates
FA formation, thus promoting cell adhesion. A critical
component in the cell-adhesion process is the adhesome
–i.e., a complex of > 180 proteins and associated effector
partners that connect with receptors such as integrins
and Syndecan-4 [2, 3] regulating not only cell adhesion
but also other cellular processes, including cell
polarization, and migration. Cell migration is a cyclical
process that first requires cell polarization and the for-
mation of membrane protrusions at the leading edge.
Then, FA and actin microfilament bundles (i.e., stress fi-
bers) form, and cells contract/retract the rear end to
promote forward movement [4, 5]. Many receptors and
proteins are involved in cell movement, nevertheless; the
key signaling components of the adhesome that regulate
FA dynamics remain poorly defined.
An integrin and Syndecan-4 cellular counterpart posses-
sing an integrin-binding site and a heparin-binding do-
main (HBD) is the neuronal surface protein Thy-1/CD90,
a protein included in the integrin adhesome by virtue of
the Thy-1/β3 integrin interaction described initially by our
group [6, 7]. Interestingly, Thy-1/CD90 HBD has also
been involved in the formation of FA in astrocytes
through the engagement of the proteoglycan Syndecan-4
in a cooperative interaction with αvβ3 integrin [8].
Syndecan-4 possesses a cytoplasmic domain with two
conserved regions flanking a central variable region that
binds to phosphatidylinositol 4,5-bisphosphate (PIP2)
[9–11] and PKCα [12–14] and this complex has been
implicated in FA formation [15, 16]. In fibroblasts, avail-
able evidence indicates that the small GTPase Rac1 lo-
calizes to the cell leading edge after stimulation with
Fibronectin in a PKCα-dependent manner, indicating
that Rac1 is the main GTPase activated downstream of
Syndecan-4 ligation [13]. In our model of Thy-1/CD90-
induced astrocyte migration, Syndecan-4 engagement by
Thy-1/CD90 activates FAK/Rac1, which are required to
induce astrocyte polarization and migration over the
extracellular matrix (ECM) [8, 17]. However, the signal-
ing partners of Syndecan-4 linking this proteoglycan to
the FAK/Rac1 pathway are still unknown.
The cytoplasmic C2 domain of Syndecan-4 possesses an
EFYA C-terminal sequence, which binds proteins contain-
ing the post synaptic density protein, Drosophila disc large
tumor suppressor, and zonula occludens-1 protein (PDZ)
domains such as Syntenin, CASK, synectin, synbindin and
the Rac1 guanine nucleotide exchange factor (GEF) Tiam1
[18, 19]. To learn more about other possible partners of
Syndecan-4, here we performed mass spectrometry of
complexes precipitated with Syndecan-4 cytoplasmic tail
peptides and found the adaptor protein PAR-3 as a new
binding partner for Syndecan-4.
Partitioning-defective (PAR) proteins play roles in the
polarized cell migration of astrocytes, fibroblasts, and T-
cells [20, 21, 27]. For example, the leading edge of motile
cells present the PAR-6/aPKC polarization complex,
which is needed to reorient the microtubule-organizing
center, the microtubule cytoskeleton, and membrane traf-
ficking towards the leading edge [22–24]. Particularly not-
able among the PAR proteins is PAR-3, a protein related
to cell polarity in several cell types [23, 25, 26]. Most inter-
estingly, PAR-3 possesses three PDZ domains and binds
to Rac1 GEFs at the leading edge of cells, thereby spatio-
temporally controlling Rac1 activity and cell migration
[26, 27]. While polarized cell migration clearly depends on
PAR proteins, a possible role for PAR-3 as a downstream
effector of Syndecan-4 has yet to be determined.
In adult individuals, mesenchymal cells are relatively
quiescent cells that help maintain connective tissue and
regulate homeostatic functions, such as stabilizing even
the smallest blood vessels [28]. Tissue damage or inflam-
matory processes activate these cells, with fibroblasts
transforming into myofibroblasts and astrocytes into re-
active astrocytes [29]. These transformed cells are motile
and scar-forming. Although an initially beneficial
process, scarring requires fine-tuned regulations for ap-
propriate tissue repair [30–33]. Thus, understanding and
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influencing the wound-healing process necessarily re-
quires complete knowledge on the molecular mecha-
nisms governing cell migration.
Here, we used astrocytes and fibroblasts to study the
involvement of Syndecan-4 and PAR-3 in cell adhesion/
migration. The obtained research data identify a novel
signaling pathway, termed Syndecan-4/PAR-3, involved
in controlling Thy-1/CD90-induced FA dynamics in
mesenchymal cells by regulating Focal Adhesion Kinase
(FAK) autophosphorylation and Tiam1 activation. PAR-
3 binding to Syndecan-4 further suggest that PAR-3 is a
novel adhesome-associated component with an essential
role in polarized cell migration.
Methods
Cell culture
The rat astrocytic cell line DI TNC1 (ATCC CRL-2005)
was maintained in RPMI-1640 medium (GIBCO Life
Technologies) as previously described [17]. CAD cells ex-
pressing or not Thy-1/CD90 were grown in Dulbecco’s
modified Eagle’s medium: Nutrient Mixture F-12 medium
(DMEM/F12) (Gibco) containing 8% FBS and 1%
penicillin-streptomycin. Cells with silenced Thy-1/CD90
where maintained in the same medium containing 0.5 μg/
ml puromycin (Sigma-Aldrich) [7, 34]. As reported [35]
MEFs were prepared from E13.5 C57BL/6 mouse em-
bryos. Primary MEFs (passage 2) were immortalized by
transfecting them with SV40 large T-antigen (Addgene
plasmid #13970) using Fugene HD (Promega). Cells were
seeded at a ratio of 1:10 for 9 additional passages upon
reaching confluence. Immortalized MEFs were grown in
DMEM-high glucose supplemented with 10% FBS (At-
lanta Biological), 1% penicillin-streptomycin and 1% Glu-
tamax (Gibco) and used for experiments until passage 17.
Plasmids and transfections
Retroviral expression vector (pBabe-puro) encoding
Syndecan-4 fused to an extracellular HA-tag was kindly
provided by Dr. Mark Morgan (University of Liverpool,
UK) [36]. Syndecan-4-HA fragment was subcloned into
EcoRI/XhoI sites of pcDNA3.1(+) plasmid. For the live
cell experiments we used mCherry-vinculin (modified
pEGFP-C1-mCherry plasmid harboring a deletion of
the GFP gene sequence), kindly provided by Dr. Vicente
Torres (Universidad de Chile, Chile) [37]. pEGFP-C1-
Tiam1-PHnCCEx containing a mutation in the RhoK
phosphorylation site encoding for a dominant negative
mutant of Tiam1 was kindly provided by Dr. María Paz
Marzolo (P. Universidad Católica de Chile, Chile) [38].
To downregulate PAR-3 expression we used siRNA
ON-TARGET plus SMART pool (Thermo Scientific)
against rat PAR-3 or FlexiTube siRNA Mm_Pard3_4
(Qiagen) targeting mouse PAR-3. A mix of two Tiam1
siRNA targeting the human Tiam1 with 88% homology
with the rat Tiam1 sequence (Dharmacon) was used to
lower Tiam1 expression. Silencer® Negative Control No.
1 (Ambion™) or AllStars (Qiagen) were used as siRNA
negative control. Plasmids and siRNAs transfections of
DI TNC1 cells were performed with Amaxa Nucleofec-
tor following manufacturer’s recommendations for astro-
cytes (Amaxa Biosystems, Lonza). Lipofectamine
RNAiMAX Reagent and Lipofectamine 3000 (Thermo
Fisher Scientific) were used to transfect MEFs.
Antibodies and reagents
The recombinant protein Thy-1-Fc and TRAIL-R2-Fc
were obtained as reported [6, 8, 39], and used coupled to
protein A (Sigma-Aldrich) for cell stimulation. Complexes
were incubated in a 10:1 (recombinant fusion protein:
Protein-A) ratio for 60min at 4 °C, shaking gently [40].
Immunofluorescence reagents were rhodamine-
conjugated phalloidin and DAPI (diamidino-2-phenylin-
dole) (Sigma-Aldrich). Antibodies were rabbit anti-PAR-3
(Merck, Millipore, and ProteinTech), mouse anti-HA
mAb and rabbit anti-giantin (Covance Research Products),
mouse anti-vinculin mAb and anti β-actin from Sigma-
Aldrich, and goat anti-mouse IgG conjugated to Alexa
fluor 488, goat anti-mouse IgG or goat anti-rabbit IgG
conjugated to Alexa fluor 546 (Molecular Probes). Other
antibodies used were rabbit anti-Syntenin (Synaptic Sys-
tems), rabbit anti-Syndecan-4 (Abbexa) and rabbit anti-
Tiam1 (Santa Cruz Biotechnology), rabbit anti-p-FAK
(Tyr397) (Upstate Biotechnology), rabbit anti-FAK (Cell
Signaling), and horseradish peroxidase-conjugated goat
anti-mouse IgG polyclonal antibody (Bio-Rad Laborator-
ies, Inc.) or goat anti-rabbit IgG, mouse anti-rabbit IgG
light chain specific and goat anti-rabbit IgG Fc specific
(Jackson ImmunoResearch Labs, Inc).
Immunoprecipitation and Western blotting
DI TNC1 cells were serum-deprived for 16 h and stimu-
lated or not for 30min with a complex of Thy-1-Fc or
TRAIL-R2-Fc conjugated to Protein A, or 3% FBS as a
migration-inducing control. Then, cells were lysed (50mM
Hepes-KOH, pH 7.4, 50mM NaCl, 750 μM CaCl2, 1mM
MgCl2, 1% Triton X-100, 2mM DTT) supplemented with
protease and phosphatase inhibitor cocktail (Biotool) and
pre-incubated with streptavidin-coated Sepharose beads to
clean lysates of biotin containing proteins. Soluble fraction
of lysates was incubated with streptavidin-Sepharose beads
coupled to biotinylated peptides (15 μg/sample) corre-
sponding to 10 amino acids of the cytoplasmic tail of
Syndecan-4 (K K A P T N E F Y A) or control peptides in
which the last 4 amino acids were replaced by glycine (K K
A P T N G G G G) [41]. Samples were separated by SDS-
PAGE and silver stained. In-gel bands corresponding to
Syndecan-4 tail-precipitated proteins that were absent in
the control condition (modified peptides) were extracted
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from the gel, digested and analyzed by liquid
chromatography-tandem mass spectrometry (UNC Michael
Hooker Proteomics Center-UNC, Chapel Hill). Data, ob-
tained from two independent experiments, were searched
against publicly available databases using Mascot search en-
gine. In a different set of experiments, precipitated proteins
were immunoblotted for PAR-3 and Syntenin to corrobor-
ate mass spectrometry results.
For Syndecan-4 immunoprecipitation, cells were trans-
fected with Syndecan-4-HA plasmid; 48 h later, cells were
serum-starved for 16 h and stimulated for 30 min or not
with Thy-1-Fc or TRAIL-R2-Fc conjugated to Protein A.
Cells were lysed (20mM Tris-HCl, pH 7.4, 0.15 N NaCl
and 0.5% NP-40, supplemented with protease and phos-
phatase inhibitor cocktail) and incubated with a mouse
anti-HA antibody. Precipitated proteins were analyzed by
Western blotting for PAR-3, FAK, Syndecan-4 and Synte-
nin using rabbit polyclonal antibodies. Alternatively, MEFs
were transfected with Syndecan-4-HA plasmid and selected
with G418 (1.65mg/ml). Cells were plated at sub-con-
fluency, serum-starved for 16 h and stimulated with Thy-1-
Fc-Protein A beads for 30min or 3% FBS for 3min. Cell ly-
sates were incubated with rabbit anti-PAR-3 antibody and
precipitated proteins were analyzed by Western blotting for
HA (Syndecan-HA, mouse anti HA antibody) and Syntenin
(rabbit antibody). An HRP-conjugated goat anti-rabbit IgG,
Fc specific secondary antibody was used to detect the anti-
Syntenin antibody and avoid interferences by the light chain
immunoglobulin used to precipitate PAR-3. Antibody de-
tection was performed using an enhanced ECL detection
system (GE Healthcare). The intensity of the bands was
quantified by using ImageJ (National Institutes of Health).
Proximity ligation assay (PLA)
DI TNC1 cells were transfected with Syndecan-4-HA or
control plasmids. After 48 h, cells were serum-starved
for 30 min and stimulated or not with Thy-1-Fc or
TRAIL-R2-Fc conjugated to Protein A for 30 min. Cells
were fixed and permeabilized with 0.1% Triton for 10
min. PLA was performed using DuoLink PLA probes
and reagents (Sigma-Millipore) following the manufac-
turers protocol. Signal puncta was analyzed using the
Analyze Particles function in ImageJ software as de-
scribed below.
Indirect immunofluorescence
Cells were fixed at the indicated time points, rinsed,
permeabilized and blocked as previously reported [8].
Cells were stained with appropriate antibody as de-
scribed in each figure legend and coverslips were washed
and mounted using 10% Mowiol-2.5% 1,4-Diazabicyclo
[2.2.2] octane. Samples were visualized using a confocal
Nikon Spectral C2 Plus microscope (Plan-Apo NA1.4
60x oil) or a Zeiss LSM 510 META Laser Scanning Con-
focal Microscope (Plan-Apo 420,782–9900 63x oil).
PAR-3 and Syndecan-4 immunofluorescence
DI TNC1 cells were transfected with Syndecan-4-HA
and 15.000 cells were seeded on coverslips in 24-well
plates for 24 h. Then, cells were starved for 30 min and
stimulated or not with a complex Thy-1-Fc or TRAIL-
R2-Fc (4 μg/well) [6, 39] conjugated to Protein A in a 10:
1 ratio, for 60 min. Next, cells were processed by
immunofluorescence as described [42].
Wound healing and polarity assays
DI TNC1 cells were transfected and seeded in 24-well
plates for 24 h at 70–80% confluence. For wound healing
assays, cells were transfected with siRNA targeting PAR-3,
Tiam1 or control, or with DN-Tiam1 (dominant negative
for Tiam1), and for polarity assays, with siRNA targeting
PAR-3 or siRNA control. DI TNC1 monolayers were
scratched with a sterile micropipette tip; then, attached cells
were washed twice with PBS and left in serum-free RPMI
media for 30min before the addition of the recombinant
proteins to stimulate migration. Cells were stimulated for 7
(polarity) or 24 h (wound-healing) with Thy-1-Fc or
TRAIL-R2-Fc conjugated to Protein A as described [43].
Since cells are kept in serum-free media during the stimula-
tion period, no proliferation effect is foreseen, as we have
previously shown [17]. The cell-free area was measured at
time zero (before applying the stimulus) and at 24 h by
phase contrast microscopy to quantify wound closure
[43] using ImageJ software [44]. In cell polarization experi-
ments, samples were fixed after stimulation and stained for
nucleus (DAPI) and the Cis-medial Golgi protein giantin
(rabbit anti-giantin from Covance Research Products). Cells
were considered polarized when the Golgi signal was local-
ized in front of the nucleus within an angle of 120° (see
Fig. 2b). One hundred cells were monitored per condition,
and cell polarization was evaluated as the percentage of
cells along the wound border exhibiting polarized Golgi
structures [45].
Far-indirect immunofluorescence for active GEFs
DI TNC1 cells were transfected with siRNA PAR-3 or
siRNA control and seeded in 8-well Falcon culture slides
(Corning) for 24 h at 50% confluence. Cells were serum-
starved for 30 min and stimulated or not with Thy-1-Fc
or TRAIL-R2-Fc conjugated to Protein A. Then, cells
were subjected to a modified protocol of the original
Far-immunofluorescence method previously described
[46]. Briefly, cells were fixed, permeabilized and blocked
as for regular immunofluorescence [43]. Samples were
then incubated with GST-Rac1G15A or GST purified re-
combinant protein for 60 min and washed. Subsequently,
samples were incubated with anti-GST antibody
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followed by secondary Alexa Fluor 546 goat anti-rabbit.
GST-recombinant proteins were prepared according to
the original report [47]. Immunofluorescence obtained
with GST only was considered as background and sub-
tracted from all samples. Similarly, in other experiments
cells were stained for GST and Tiam to determine the
levels of Tiam activation in situ in astrocytes. The co-
localization between GST-Rac1G15A with Tiam was an-
alyzed using ImageJ [44].
Focal adhesion analysis
DI TNC1 cells were transfected with siRNA PAR-3 or
siRNA control. For video microscopy siRNAs were co-
transfected with mCherry-vinculin. Cells were then
seeded in coverslips in 24-well plates for assembly and
disassembly assays, or in 8-well Lab-Tek II chambered
coverglass (Nunc) for time-lapse video microscopy. For
assembly assays, cells were serum-starved for 30 min and
stimulated or not with Thy-1-Fc-Protein A or TRAIL-
R2-Fc-Protein A for 15 min. For disassembly assays, cells
were serum-starved during 30min and treated with
10 μm Nocodazole (Sigma, Aldrich) for 4 h (to disrupt
microtubules); then, Nocodazole was removed (time
zero [t0]) promoting polymerization of microtubules and
disassembly of FAs. The stimuli (Thy-1-Fc-Protein A or
its control TRAIL-R2-Fc-Protein A) were applied for dif-
ferent time points (0–60 min) as indicated. Cells were
fixed and immunofluorescence with anti-vinculin anti-
body was performed. For time-lapse video microscopy
images were captured starting at time zero up to 30 min
(every 1 min) in a temperature controlled chamber as-
sembled in an epifluorescence Nikon Eclipse Ti micro-
scope. Kinetics of focal adhesions was measured from
these time-lapse experiments, scoring at least 10
mCherry-positive focal adhesions per experiment.
Similarly, experiments to follow FA dynamics in MEFs
were performed as described above, but cells were co-
transfected with siRNA targeting PAR-3 or siRNA con-
trol and siGlo RNAi (GE Dharmacon). Cells were then
treated with 0,1 μm Nocodazole for 4 h and stimulated
with Thy-1-Fc-Protein A or TRAIL-R2-Fc-Protein A as
described for astrocytes.
Quantification of focal adhesion area and number was
performed following previously described protocols [42].
The average number of FAs as well as the average area
per FA was determined for at least 50 cells in each ex-
perimental condition using the ImageJ/Fiji program and
the function ‘Analyze particles’ [44].
FAK autophosphorylation
Cells were transfected or not with siRNA PAR-3 or
siRNA control and seeded in 24-well plates for 24 h at
50% confluence for DI TNC1. Cells were manipulated as
described for FA disassembly assay (see above). The
stimuli (Thy-1-Fc-Protein A or TRAIL-R2-Fc-Protein A)
were applied for different time points (0–60min). Then,
cells were lysed in Laemmli buffer containing the prote-
ase and phosphatase inhibitor cocktail, analyzed by
Western blot (see above) for p-FAK (Tyr397) and total
FAK.
Tiam1 activity
DI TNC1 cells were grown in 10 cm plates, and Tiam1
activity was measured using an affinity precipitation
assay previously described [48]. Briefly, cells were
serum-starved for 16 h and subsequently stimulated with
previously fixed CAD (shThy-1) or CAD (shLuc) cells as
reported [39] for different periods of time. Thy-1/CD90
is highly expressed on the surface of CAD cells and this
mode of activation, previously validated by our group, is
used when a large amount of Thy-1-Fc protein is re-
quired to stimulate cells [17]. After stimulation, cells
were washed and scraped in lysis buffer (25 mM HEPES,
pH 7.4, 0.1M NaCl, 1% NP40, 5 mM MgCl2, 10% gly-
cerol, 1 mM DTT, 10 μg/ml leupeptin, 10 μg/ml aproti-
nin and 1mM sodium orthovanadate). Next, cell lysates
were incubated with 30 μg of GST-Rac1G15A bound to
GSH-agarose beads for 1 h at 4 °C and mixed gently on a
rocking shaker. After washing, beads were resuspended
in Laemmli buffer. Samples were resolved by SDS-
PAGE, transferred to nitrocellulose membrane, which
was blocked with 5% fat-free milk in 0.1% Tween-PBS,
and incubated with anti-Tiam1 (1:1000). Active Tiam1
was determined by Western blot analysis from the pre-
cipitated fraction and normalized to total protein
(input).
Statistical analysis
All data are expressed as the mean ± standard error of
mean (mean ± s.e.m.) from three independent experiments
(n = 3). For each experimental condition at least 50 cells
were evaluated per every independent experiment. Data
were compared through non-parametric Mann-Whitney
analysis, 1-way or 2-way ANOVA, accordingly. Significant
differences (*) were established at P < 0.05.
Results
PAR-3 interacts with Syndecan-4
The C-terminal PDZ-binding domain of Syndecan-4
(C2) associates with various PDZ-containing proteins or
other molecules involved in cell migration [18]. There-
fore, polarized cell migration was stimulated with fetal
bovine serum (FBS) to identify C2-recruited Syndecan-4
binding proteins. The astrocyte cell line DI TNC1 was
selected as a mesenchymal-type cell model based on
prior use in studies related to cell adhesion and migra-
tion [6–8, 17, 43]. DI TNC1 cells were first stimulated
with FBS, and lysates precipitated using streptavidin-
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Sepharose beads coupled to biotinylated Syndecan-4
peptides corresponding to the C-terminal last 10 amino
acids of the cytoplasmic domain (Additional file 1A). As
a control peptide, the same 10 amino acids with the last
4 amino acids (EFYA) replaced by glycine were used
[41]. The associated proteins were separated in an SDS-
PAGE gel and Silver stained (Additional file 1B). The
bands of interest were cut from the gel and identified by
mass spectrometry. Astrocytes stimulated with FBS pre-
sented various proteins binding to the Syndecan-4 cyto-
plasmic peptide. PAR-3 was one of the detected
Syndecan-4 binding proteins, making this the first study
to describe such an interaction (Table 1). Other proteins
included Syntenin (AF248548) (Table 1), a protein that
serves as a good control due to its known Syndecan-4
C2 domain binding properties [49]. Syntenin directly
interacts with the Syndecan-4 EFYA sequence, making it
a perfect experimental control for the specificity of the
biotinylated peptides used in the precipitation assays
[18]. Noteworthy, because these experiments are per-
formed adding excess of ectopic peptides (15 μg/sample),
no competition between PAR-3 and Syntenin for the
biotinylated peptides is foreseen.
To confirm PAR-3/Syndecan-4 binding, the obtained
lysate precipitates were also analyzed through Western
blotting with the anti-PAR-3 and anti-Syntenin anti-
bodies. Full length PAR-3 (180 kDa) and Syntenin were
detected when precipitating with wild-type but not con-
trol Syndecan-4 peptides in non-stimulated cells (Fig. 1a
and b). Cell stimulation with FBS or Thy-1-Fc (a fusion
protein of the cell adhesion molecule Thy-1/CD90) in-
creased Syntenin precipitation with the biotinylated
wild-type peptide, but PAR-3 precipitation was un-
affected or only slightly affected (Fig. 1a and b). Simi-
larly, when astrocytes transfected with hemagglutinin
(HA)-tagged Syndecan-4 were used for Syndecan-4 im-
munoprecipitation, we observed a modest increase in
full length PAR-3 co-precipitated in Thy-1-Fc-stimulated
cells than in non-stimulated or cells treated with
TRAIL-R2-Fc (Fig. 1c). As in previous studies [6, 43],
we used a non-related protein (TRAIL-R2) fused to a Fc
fragment (TRAIL-R2-Fc) as a negative control of the fu-
sion protein Thy-1-Fc. We have previously shown that
TRAIL-R2-Fc neither binds to cell surface receptors nor
elicits cellular responses [8, 17, 43, 50]. Additionally, as
part of the complex precipitating with Syndecan-4-HA,
we found Syntenin and FAK, two proteins involved in cell
migration and known to interact with PAR-3 [51] (Fig.
1c). Syndecan-4 was also detected as an immunoprecipita-
tion control in these experiments. Furthermore, in situ
Proximity Ligation Assay (PLA) showed that PAR-3 inter-
acts very closely (< 40 nm) with Syndecan-4 in Syndecan-
4-HA-transfected astrocytes (Fig. 1d). The abundance of
this interaction was also significantly increased after Thy-
1-Fc stimulation, but not in non-stimulated cells or cells
treated with TRAIL-R2-Fc (Fig. 1e).
Altogether, these results indicate that PAR-3 binds to
Syndecan-4 and that its interaction could be regulated to
a certain extend during FBS- or Thy-1/CD90-induced
cell migration.
Table 1 Mass spectrometry data showing the identity of the proteins precipitated with biotinylated peptides of the Syndecan-4
cytoplasmic tail
Protein Name Species Database
Accession ID
MW (Da) Peptide
Counta
MS & MS/MS
Scoreb
Peptide
Sequenced
Ion Scorec
Scoring
Thresholdd
Atypical protein kinase
C isotype-specific
interacting (PAR-3)
Rattus norvegicus Q9Z340.1 149,356.5 36 315 177 56
Tubulin, alpha 1C Rattus norvegicus AAH78829.1 49,905.5 8 185 159 56
Tubulin beta chain 15 Rattus norvegicus Q3KRE8.1 49,904.9 9 151 115 56
Insulin-like growth factor
binding protein 5 protease
Rattus norvegicus AAD52683.1 51,297.7 12 227 191 56
Type I keratin KA10 Rattus norvegicus DAA04466.1 56,470.5 7 69 53 56
Actin beta Rattus norvegicus AAH63166.1 41,723.7 20 635 487 56
Heterogeneous nuclear
ribonucleoprotein
A2/B1/B0
Mus musculus AAN16352.1 37,379.7 11 101 58 78
Syntenin-1 Rattus norvegicus NP_114192.1 32,402.7 14 384 299 56
Streptavidin core, residues
13,139 pH 4.5, chain B
Streptomyces avidinii 1SWAB2 9191.5 6 549 498 78
aNumber of peptides that match the theoretical digest of the primary protein identified
bQuality score of peptide-mass fingerprint matches and of MS/MS peptide fragment ion matches, if MS/MS data were generated
cQuality score of only MS/MS peptide fragment ion matched, if MS/MS data were generated
dSignificant score threshold. For each given database, a hit with an “MS & MS/MS Score” above the indicated value was considered a significant identification (p <
0.05). Only hits with an “MS & MS/MS Score” above this value are reported
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Fig. 1 Thy-1 treatment induced association of PAR-3 with Syndecan-4 in DI TNC1 astrocytes. a Cell lysates obtained upon FBS or (b) Thy-1-Fc-
Protein A (Thy-1) stimulation were precipitated using biotinylated peptides consisting in the 10 amino acids of Syndecan-4 cytoplasmic domain
(SDC4) or control peptides, in which the last 4 amino acids (EFYA) were replaced by glycine. Samples were immunoblotted for PAR-3. Syntenin
was used as a precipitation control since it interacts directly with the Syndecan-4 EFYA sequence. c Syndecan-4-HA transfected DI TNC1 cells
were stimulated with Thy-1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL) as a negative control. Cell lysates were immunoprecipitated with
the anti-HA antibody and immunoblotted for PAR-3, FAK, Syndecan-4, or Syntenin. d Association between PAR-3 and Syndecan-4 was evaluated
by Proximity Ligation Assay (PLA). DI TNC1 cells were transfected with Syndecan-4-HA or with the empty plasmid. Subsequently, cells were serum
starved for 30 min and stimulated or not (NS) with Thy-1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL), fixed and processed for PLA using
antibodies against PAR-3 or HA. Pictures are representative of PLA puncta observed for each condition as indicative of the interaction between
PAR-3 and Syndecan-4-HA. Lower panels show magnification of the indicated area. Magnification bar = 10 μM. e Graph shows the number of PLA
puncta per cell. ***P < 0.001
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PAR-3 is involved in Thy-1/CD90-induced cell adhesion
and migration, but not polarization
Prior research reports indicate that neuronal Thy-1/
CD90 engages Syndecan-4 in a cooperative interaction
with αvβ3 integrin to initially induce FA formation in as-
trocytes (~ 30 min). Sustained Thy-1/CD90 stimulation
leads to Rac1 activation and astrocyte migration (> 60
min) [8, 17]. Considering that PAR-3 and Syndecan-4
form a complex in astrocytes, termed herein as the
Syndecan-4/PAR-3 signaling complex, and that the
abundance of such complexes changes in Thy-1/CD90-
stimulated cells (Fig. 1d and e), the participation of
PAR-3 in Thy-1/CD90-induced adhesion, polarization,
and migration was explored.
First, PAR-3 full length (180 kDa) as well as its isoforms
(150 and 100 kDa) were silenced using a siRNA pool (Fig. 2a).
Cell migration was subsequently monitored in a wound-
healing assay after 24 h of treatment with Thy-1-Fc. Cells with
silenced PAR-3 isoforms and stimulated with Thy-1-Fc evi-
denced inhibited wound closure compared with the respective
siRNA controls (Fig. 2a).
Second, cell polarization was evaluated using the same
technique as above, but wound-healing was monitored
after 7 h of Thy-1-Fc treatment. Golgi/nuclei staining
distinguished non-polarized from polarized cells (i.e.,
Golgi apparatus in front of the nucleus and facing the
wound border within a 120° angle [45] (Fig. 2b, left
panel). PAR-3 silencing did not abolish Thy-1-Fc-in-
duced Golgi polarization (Fig. 2b). This polarization
process was also unaffected by PAR-3 silencing in non-
stimulated and TRAIL-R2-Fc control cells (Fig. 2b).
Finally, cell adhesion was evaluated with a FA assem-
bly assay, where an anti-vinculin antibody was employed
to detect FAs by immunofluorescence. Our results show
that PAR-3-silenced astrocytes stimulated for 30 min
with Thy-1-Fc had fewer total FAs, but, unexpectedly,
individual structures were larger and longer than in con-
trol cells (Fig. 2c). In contrast, Thy-1-Fc-stimulated as-
trocytes in siRNA control cells presented more and
larger FAs than did non-stimulated and TRAIL-R2-
treated control cells (Fig. 2c).
These results show that PAR-3 participates in the sig-
naling pathways required for adhesion and migration.
However, in agreement with a previous report that used
astrocytes stimulated with FBS [27], PAR-3 in our model
system was not involved in Golgi polarization.
PAR-3 regulates FA disassembly and favors FAK
dephosphorylation
Considering the surprising results indicating that larger and
longer FAs were detected in PAR-3-knockdown cells, a pos-
sible role of PAR-3 in FA disassembly was evaluated. Cells
were first treated with Nocodazole, a microtubule-
depolymerizing drug [52] that blocks FA turnover [53, 54].
Nocodazole was washed out and cells were immediately
stimulated with Thy-1-Fc; FA disassembly was then analyzed
at different time points. Through vinculin staining, Thy-1-
Fc-stimulated astrocytes evidenced more rapid FA disassem-
bly (i.e., fewer and smaller FAs 5min post-Nocodazole wash-
out; Fig. 3a) than non-stimulated and TRAIL-R2-treated
controls (i.e., no change in FA quantity, smaller FAs 15min
post-Nocodazole washout; Fig. 3a).
Since Thy-1-Fc speeds up FA disassembly after Nocodazole
wash-out, we wanted to analyze the role of PAR-3 in this
process. For this, PAR-3-silenced astrocytes were treated with
Nocodazole and analyzed using time-lapse video microscopy
immediately after washout. FA disassembly was delayed (i.e.,
22 ± 1min) in Thy-1-Fc-stimulated, PAR-3-silenced cells as
compared with Thy-1-Fc-stimulated, siRNA-control cells (i.e.,
8 ± 1min) (Fig. 3b) (Movie S1 and S2). For PAR-3-silenced
cells that were non-stimulated or TRAIL-R2-treated, FA disas-
sembly was undetectable during the 30-min recording (Movie
S3 and S4). In turn, siRNA control cells that were non-
stimulated or TRAIL-R2-treated showed FA disassembly
within 20± 1min (Fig. 3b). Taken together, the evidence indi-
cates that PAR-3 regulates FA disassembly.
After identifying these key components in FA disassem-
bly, investigation was conducted on a possible underlying
signal transduction mechanism. Our previous reports in-
dicate that αvβ3 integrin and Syndecan-4 bind to Thy-1/
CD90 and trigger signaling events that include activation
of FAK, and PI3K downstream of integrin activation [17].
Consequently, PIP3 increases at the plasma membrane
allowing translocation of a Rac1 GEF that leads to the ac-
tivation of Rac1 and cell migration, events that also in-
volve engagement of Syndecan-4 and the activation of
PKCα (Fig. 3c) [8, 17].
Additional reports also indicate a role for FAK in FA
turnover, where Y397-FAK autophosphorylation is an
important molecular marker for events linked to the
control of FA dynamics. While higher phosphorylation
levels are observed when FAs are stabilized, Y397 de-
phosphorylation is associated with FA disassembly [55].
Here, we showed that FAK co-precipitates with
Syndecan-4-HA (Fig. 1c). Therefore, the possible effects
of Thy-1-Fc on FAK phosphorylation during FA disas-
sembly were assessed by monitoring Y397-FAK auto-
phosphorylation after Nocodazole washout at different
time points. Aligning with accelerated FA disassembly
promoted by Thy-1-Fc (Fig. 3b), FAK dephosphorylation
was detected as early as 5 min after Nocodazole washout
(Fig. 3d, top panels). However, in PAR-3-silenced cells,
Thy-1-Fc stimulation showed no differences in Y397-
FAK autophosphorylation levels (Fig. 3d, bottom panels).
Data shown in Fig. 3d is quantified in Fig. 3e.
Therefore, these results indicate that PAR-3 controls
FA disassembly and that the presence of PAR-3, during
this process, favors Y397-FAK dephosphorylation.
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Fig. 2 PAR-3 knockdown impaired astrocyte migration and adhesion, but not Golgi polarization induced by Thy-1. a Immunoblotting for PAR-3
isoforms in cells transfected with PAR-3 siRNA compared to control siRNA. Actin was the loading control. Migration was evaluated using the
wound-healing assay. Evaluated were DI TNC1 cells with silenced PAR-3 or control, stimulated or not (NS) with Thy-1-Fc-Protein A (Thy-1) or
TRAIL-R2-Fc-Protein A (TRAIL). Pictures show overlapping images of wound closure at time zero (red) and after 24 h (green). Dotted line shows
the wound-closure boundary. Graph shows wound closure in relative units. b DI TNC1 astrocytes, transfected as in (a), were stimulated with Thy-
1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL) for 7 h. After fixation, cells were stained for nucleus (DAPI) and Golgi apparatus using an
anti-giantin antibody. Golgi (red) positioning within an angle of 120° in front of the nucleus (blue), facing the wound, was considered polarized
(1). Non-polarized cells are labelled as (2). Arrow shows the direction of migration. One hundred cells were monitored per condition. Graph
shows the percentage of polarized cells. Scale bar = 10 μm. c DI TNC1 astrocytes, transfected as in (a), were stimulated for 15 min. FAs were
visualized by immunofluorescence using an anti-vinculin antibody (red) and DAPI for nuclei (blue). Scale bar = 10 μm. Image analyses were
performed with the Analyze Particles Tool in the Fiji image processing software [44]. Values in the graphs represent the mean ± s.e.m. from 3
independent experiments (n = 3) determined from at least 50 cells in each experimental condition per experiment. Significant differences are
indicated as *P < 0.05
Valdivia et al. Cell Communication and Signaling          (2020) 18:129 Page 9 of 19
Fig. 3 PAR-3 silencing impaired Thy-1-accelerated microtubule-dependent focal adhesion disassembly. a DI TNC1 cells treated with Nocodazole
and washout were stimulated or not (NS) with Thy-1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL) for different time periods. FAs were
detected by immunofluorescence staining for vinculin (red) and nuclei (blue). Scale bar = 10 μm. Graphs show quantification of the FA number
per cell (left panel) and average area of FAs (right panel) observed in DI TNC1 astrocytes after the indicated treatments. Values in the graphs
represent the mean ± s.e.m. determined from at least 50 cells in each experimental condition per experiment. b DI TNC1 astrocytes co-transfected
with mCherry-vinculin and siRNA (control or PAR-3) were treated with Nocodazole and washout. Cells were then stimulated as in (a), and a 30-
min time-lapse microscopy video was recorded. Values in the graphs represent the mean ± s.e.m. determined from scoring at least 10 mCherry-
positive focal adhesions per experiment. c Model depicting the interaction of αvβ3 integrin and Syndecan-4 with Thy-1, which triggers signaling
events that include activation of FAK and PI3K generating PIP3. An unidentified Rac1 GEF, is then recruited to the plasma membrane, where it
activates Rac1 and leads to cell migration. d DI TNC1 astrocytes, transfected as in (a), were treated with Nocodazole and washout, and cells were
stimulated for different time periods (0–15min). Cell lysates were immunoblotted for p-FAK or total FAK. e Graph values are compared against
the normalized time 0 and represent the average numbers obtained from the ratio of p-FAK/FAK densitometric data analysis. All graphs show the
mean ± s.e.m. of n = 3. Significant differences compared to control conditions are indicated as *P < 0.05, **P < 0.01, and ***P < 0.001
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PAR-3 regulates Tiam1 activation during Thy-1-induced
migration
Our previous work showed that Thy-1/CD90 engage-
ment of αvβ3 integrin and Syndecan-4 activates Rac1 in
astrocyte migration via an unknown Rac1 GEF (Fig. 3c)
[17]. To further understand how PAR-3 is involved dur-
ing Thy-1-induced migration, we first evaluated if PAR-
3 participates in the activation of Rac1 GEFs using a
modified Far-indirect immunofluorescence method [46].
This method was modified by using a nucleotide-free re-
combinant Rac1 protein (GST-Rac1G15A), which
strongly binds to active Rac1 GEFs [47]. Therefore,
GST-Rac1G15A was added to interact with active Rac1
GEFs present in cells expressing endogenous or reduced
PAR-3 levels. As a result, higher levels of active Rac1
GEFs were detected in Thy-1-Fc-stimulated, siRNA-
control cells than in TRAIL-R2-Fc cells (Fig. 4a, left
panels). In contrast, cells with reduced PAR-3 levels had
very low levels of activated Rac1 GEFs despite Thy-1-Fc
or TRAIL-R2-Fc treatment (Fig. 4a, right panels).
Since PAR-3 can bind the GEF Tiam1 to activate Rac1
[56], we hypothesized that most of the active Rac1 GEFs
observed in the Fig. 4a after Thy-1 stimulation could be
Tiam1. To test this hypothesis, astrocytes were trans-
fected with Tiam1-specific siRNA or with a dominant
negative form of Tiam1 and wound-healing assays were
conducted. Tiam1 silencing or dominant-negative ex-
pression prevented the enhancing effect of Thy-1-Fc on
cell migration, suggesting that Tiam1 is required for
Thy-1-Fc-induced astrocyte migration (Fig. 4b). Next,
Tiam1 activation was confirmed by an affinity precipitation
assay [17, 48]. Due to the amount of stimulus required to
perform this assay, we used fixed CAD cells as a source of
Thy-1/CD90 to stimulate astrocytes. This mode of activa-
tion has been previously validated by our group [17]. We
found that CAD cells expressing Thy-1 on their surface
induced Tiam1 activation in astrocytes after 30–60min of
treatment (Fig. 4c), which is in line with Tiam1
involvement in signaling pathways that promote astrocyte
migration [17].
To prove that the active Rac1 GEF, identified in cells
through GST-Rac1G15A binding, and Tiam1 coincide in
cellular localization, we performed the same Far-indirect
immunofluorescence experiment but, evaluated co-
localization of anti-GST and anti-Tiam1 antibodies.
More Tiam1 signal (red fluorescence) was detected at
the plasma membrane of Thy-1-stimulated control cells
(siCTRL) compared with TRAIL-R2-treated cells (Fig. 5,
top panels, ±Thy-1-Fc), indicative of increased amount
of active Tiam1 in cells stimulated with Thy-1/CD90.
Importantly, the active Tiam1 signal coincided with the
staining of the GST-Rac1G15A probe, suggesting that
the active Rac1 GEF observed in Fig. 4a corresponds to
Tiam1. Finally, we evaluated if Syndecan-4 was necessary
for Tiam1 activation. To accomplish this, the same ex-
periment was repeated in Syndecan-4-silenced cells. The
co-localization between GST-Rac1G15A probe and
Tiam1 observed in siCTRL cells does not occur when
cells are depleted of Syndecan-4 (Fig. 5, bottom panels).
Syndecan-4 silencing decreased cell spreading but did
not affect cell viability (data not shown) in these experi-
ments. These results agree with previous reports [8, 57,
58]. Therefore, these results suggest that active Tiam lo-
calizes to the plasma membrane in lamellipodia-like pro-
trusions in a Thy-1/CD90- and Syndecan-4-dependent
manner (Fig. 5, Zoom and heatmap boxes).
Altogether these results indicate that PAR-3 regulates
cell migration by (i) associating with the adhesome pro-
tein Syndecan-4, (ii) favoring FAK dephosphorylation
during FA disassembly, and (iii) regulating Tiam1 activa-
tion. Considering our previous report indicating the re-
quirement of Rac1 activation for astrocyte migration
[17], we suggest that Tiam1 is the missing Rac1 GEF
that activates Rac1, downstream of integrin/Syndecan-4
engagement by Thy-1-Fc.
Syndecan-4/PAR-3 signaling participates in FA
disassembly in fibroblasts
Once the existence of the Syndecan-4/PAR-3 complex was
established, specifically in relation to controlling cell
migration in astrocytes, the presence and functionality of this
complex was tested in a different mesenchymal cell, namely
mouse embryonic fibroblasts (MEFs). Unlike the employed
astrocyte cell line, MEFs are primary cells immortalized and
used for few passages only; therefore, they are a complemen-
tary mesenchymal cell model. PAR-3 was immunoprecipi-
tated in MEFs expressing Syndecan-4-HA, and Syndecan-4
co-immunoprecipitation was detected by immunoblotting.
Syndecan-4 interacted with PAR-3 in non-stimulated cells,
as well as in Thy-1-Fc or FBS-stimulated cells (Fig. 6a). Of
note, the amount of Syndecan-4 precipitated with PAR-3
was higher in Thy-1-Fc or FBS-stimulated cells (Fig. 6a)
compared with non-stimulated cells. Similarly, Syntenin re-
cruitment to immunoprecipitated Syndecan-4 was also in-
duced by stimulation (Fig. 6a). These findings indicate that
the Syndecan-4/PAR-3 complex exists in MEFs and that the
amount of PAR-3 and Syndecan-4 complex formation in-
creases after either Thy-1-Fc or FBS stimulation.
As previously shown for astrocytes, the total quantity
and average individual area of FAs increased in control
cells after Thy-1-Fc stimulation and in the absence of
PAR-3 these FAs were larger (Fig. 2c). In fibroblasts,
PAR-3 silencing (Fig. 6b) resulted in cells with a similar
number of FAs after Thy-1-Fc stimulation (Fig. 6c and
d), but with significantly larger FAs in Thy-1-Fc-stimu-
lated (3.47 μm2; Fig. 6e) than control MEFs (2.6 μm2; Fig.
6e).
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Fig. 4 Thy-1-induced astrocyte migration requires PAR-3-dependent Tiam1 activation. a PAR-3 silenced DI TNC1 astrocytes were stimulated with
Thy-1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL) for 60 min. Cells were fixed, and active Rac1 GEF was detected by
immnunofluorescence using GST-Rac1G15A and anti-GST (purple) and Phalloidin (green). The white rectangle indicates the zoomed area. The
color map indicates levels of Rac1 GEF activation, going from 0 (blue) to 256 (white). Scale bar = 10 μm. b DI TNC1 cells transfected with siRNA
control (siCTRL), siRNA Tiam1 (siTiam1), or dominant negative Tiam1 (Tiam1-DN). The Western blot shows levels of Tiam1 in siRNA-transfected
cells. Migration was evaluated using the wound-healing assay, and cells were stimulated as in (a) for 24 h. Images show wound closure at time
zero (green) and after 24 h (red). c DI TNC1 cells stimulated or not (NS) with endogenous Thy-1 from fixed CAD cells for different periods of time.
Active Tiam1 was affinity-precipitated using GST-Rac1G15A coupled to GSH-agarose beads and immunoblotted for Tiam1. Numbers in the graphs
represent the average fold-increase of Tiam1 activity normalized to total Tiam-1. All graphs show the mean ± s.e.m. of n = 3. Significant
differences compared to control conditions are indicated as *P < 0.05
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To further corroborate the effect of PAR-3 in MEFs during
FA disassembly, MEFs with silenced PAR-3 were treated
with Thy-1-Fc or TRAIL-R2-Fc immediately after Nocoda-
zole washout, and FAs were analyzed. FA disassembly was
accelerated in control cells stimulated with Thy-1-Fc (begin-
ning at 2.5min, peak at 5min; Fig. 6f) compared to control
cells treated with TRAIL-R2-Fc (beginning at 5min; Fig. 6f).
At 2.5min in these control cells, FAs were less abundant
and smaller in size in Thy-1-Fc-stimulated than in TRAIL-
R2-Fc-treated MEFs (Fig. 6f, g and h). In line with the results
obtained in astrocytes, this effect was not observed after si-
lencing PAR-3, a condition in which FAs did not disassemble
in cells treated either with Thy-1-Fc or TRAIL-R2-Fc, at least
during the observation period (Fig. 6f, g and h).
Therefore, these results confirm that PAR-3 is needed
for Thy-1-Fc-induced FA disassembly in MEFs. In
addition to the aforementioned findings, this outcome
demonstrates that Syndecan-4/PAR-3 binding, as part of
the adhesome complex, is a common mechanism used by
mesenchymal cells, not just astrocytes, to promote polar-
ized cell migration.
Discussion
Fully discovering the signaling pathways that govern cell
migration is essential for understanding important pro-
cesses, such as scarring and wound-healing. Syndecan
proteins and syndecan signaling partners play key roles
in these processes. Nevertheless, the contributions of
syndecan signaling partners to cell adhesion and migra-
tion are poorly characterized. This study is the first to
report on the participation of Syndecan-4/PAR-3 signal-
ing in FA disassembly in mesenchymal cells, specifically
astrocytes and fibroblasts, two cell-types that play a key
role in scar formation [31, 32].
One novel research finding was that the adapter pro-
tein PAR-3 is an associated member of the adhesome
and a partner for Syndecan-4. The EFYA sequence in
the C-terminal region of syndecan proteins binds with
PDZ domain-containing proteins [23, 25, 26]. Several
syndecan-binding proteins containing PDZ domains,
such as Syntenin, CASK, Synectin, Synbindin, and
Tiam1, have been previously described. In particular,
PAR-3 contains three PDZ domains [59]. These domains
Fig. 5 PAR-3-induced Tiam1 activation after Thy-1/CD90 treatment requires Syndecan-4. Syndecan-4silenced DI TNC1 astrocytes (siSynd4) or
control transfected cells (siCTRL) were stimulated with Thy-1-Fc-Protein A (Thy-1) or treated with TRAIL-R2-Fc-Protein A (TRAIL) for 60 min. Cells
were fixed, and stained for GST to detect GST-Rac1G15A (green) and for Tiam1 (red). The white rectangle indicates the zoomed area. The heat
color map indicates levels of total Tiam1 co-localization with nucleotidefree mutant of Rac1 (GST-Rac1G15A) at the membrane, as indicative of
Tiam1 activation. Scale bar = 10 μm
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Fig. 6 Thy-1-induced Syndecan-4/PAR-3 association is needed in FA dynamics in mouse embryonic fibroblasts. a MEFs transfected with
Syndecan-4-HA were stimulated or not (NS) with Thy-1-Fc or fetal bovine serum (FBS). PAR-3 was immunoprecipitated (IP) from the lysates, and
Syndecan-4 was detected with an anti-HA antibody (SDC4-HA). Syntenin and PAR-3 were immunoblotted as positive and an IP control,
respectively. IgG was used as a negative IP control. b MEFs transfected with the siRNA control or PAR-3 were analyzed by Western blotting for
PAR-3 expression. Tubulin was used as a loading control. c MEFs co-transfected with siGlo and siRNA control or PAR-3 were stimulated with Thy-
1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL) for 15 min. FAs and nuclei were respectively visualized by vinculin staining (red) and DAPI
(blue). Transfected cells were identified by the siGlo signal (green). Graphs show the mean ± s.e.m. for the number (d) and average area (e) of FAs
from at least 50 cells. MEFs were transfected as in (c), incubated with Nocodazole and washout, and immediately stimulated as in (c) for different
time periods. Graphs show the mean ± s.e.m. for the number (f) and average area (g) of FAs from at least 50 cells. Significant differences are
indicated as *P < 0.05, **P < 0.01, and ***P < 0.001. (h) Cells were co-transfected with Paxillin-EGFP and siRNA (control or PAR-3). Shown are
representative images for non-stimulated cells (t0) and cells stimulated with Thy-1-Fc-Protein A (Thy-1) or TRAIL-R2-Fc-Protein A (TRAIL) for 2.5
min (t2.5). Scale bar =10 μm
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allow PAR-3 to interact with several proteins, including
cell-cortex proteins associated with the cytoskeleton [18,
60]. The present study is the first to directly investigate
the interaction between Syndecan-4 and PAR-3; more-
over, we showed that its interaction depends on the EFYA
sequence present in the Syndecan-4 tail. The obtained
findings sustain that a Syndecan-4/PAR-3 interaction ex-
ists, thus providing new insights into the signaling mecha-
nisms downstream of Syndecan-4 and into the role of
PAR-3 in polarized cell migration. A noticeable feature of
Syndecan-4 is that it signals forming oligomers [10], thus
Syndecan-4 could bind independently to PAR-3, Syntenin,
Tiam1, and FAK bringing together all these proteins in a
signaling complex.
All PAR-3 spliced variants (i.e., 180 kDa, 150 kDa,
and 100 kDa) have the three PDZ domains, so they
can potentially bind Syndecan-4 through its EFYA se-
quence. Our work was centered on the PAR-3 full
length protein since this contains all signaling mod-
ules described to play a role during cell polarization.
However, we cannot disregard that there was a differ-
ential precipitation of the 150 and 100 kDa isoforms
while using Syndecan-4-HA compared with biotinyl-
ated peptides. Moreover, the expression of those iso-
forms seems to vary in total lysates between cell
types. Further experiments are necessary to determine
if there are other domains either in Syndecan-4 or
PAR-3 sequences that modulate the binding through
the terminal EFYA sequence or if the signaling is af-
fected when different PAR-3 isoforms bind Syndecan-
4, or even if cell confluency regulates the expression
and/or stability of PAR-3 splicing variants.
We also observed that Syndecan-4/PAR-3 binding
tends to increase after FBS or Thy-1 stimulation during
the precipitation assays, but this increase was signifi-
cantly bigger in PLA assays, suggesting that the inter-
action between Syndecan-4/PAR-3 may be lost after the
rough precipitation conditions compared with milder
conditions during in situ assays.
Another important finding was that PAR-3 is involved
in cell adhesion and migration, but not polarization of
astrocytes. Dissecting these biological processes is rele-
vant for two primary reasons. First, PAR-3 has a recog-
nized role in cell polarization as part of the PAR
complex formed by PAR-6/aPKC. This complex gener-
ates and maintains epithelial and neuronal cell polarity
[25], in addition to regulating polarized cell migration in
several species and cell lines [23, 56, 61, 62]. However,
the polarity complex of migrating astrocytes does not
contain PAR-3 [27]. The latter results agree with ours in
that PAR-3 silencing did not affect Golgi polarization.
Second, Syndecan-4 localizes and regulates FA dynamics
in cell adhesion and migration [36], and PAR-3 partially
localizes to FAs, binding and activating FAK and PI3K
to regulate adhesion and directional cell migration [21,
51]. Notwithstanding, the exact role of PAR-3 in these
events was previously unclear.
Adding to the prior results, this study also found
that PAR-3 is required for FAK dephosphorylation
occurring concomitant to FA disassembly. Itoh et al.
reported that the PDZ domains of PAR-3 interact
with the FERM domain of FAK regulating adhesion-
induced FAK phosphorylation in HeLa cells [51]. On
the other hand, FAK autophosphorylation on the
Y397 residue is required for FA dynamics and migra-
tion [55, 63]. These data consequently suggest that
PAR-3 might play a key role in regulating the FAK
phosphorylation turnover that occurs during FA as-
sembly/disassembly. However, the spatiotemporal link
of these events is unclear. We postulate that, as a re-
sult of Syndecan-4 association, PAR-3 is recruited to
FAs to regulate FAK phosphorylation, and thus, FA
turnover. This proposal is supported by the finding
that i) FAK co-precipitates with PAR-3 and
Syndecan-4, ii) the absence of PAR-3 leads to the for-
mation of long and large FAs, and that iii) specific-
ally, during FA disassembly the absence of PAR-3
prevents FAK dephosphorylation. The extensive list of
PAR-3-binding partners includes phosphatases such as
PTEN and SHP-2, both of which can subsequently dephos-
phorylate FAK [64–66]. However, the mechanism by which
PAR-3 favors FAK dephosphorylation requires further
investigation.
The current study further discovered that Syndecan-
4/PAR-3 complex regulates Tiam1 activation in astro-
cytes. In the context of PAR-3, the small GTPase Rac1,
can be regulated by the GEFs Tiam1 or TRIO [67]. Dif-
ferent research groups [56, 68] showed that PAR-3 in-
teracts with Tiam1 to mediate Rac1 activation in
migrating cells. In turn, PAR-3 sequesters TRIO in
neural crest cell-cell contacts, thereby inhibiting TRIO-
mediated Rac1 activation [67]. Related research data
show that Thy-1/CD90 induces Rac1 activation to pro-
mote astrocyte migration [17], an effect that is inhibited
by the Rac1 GEF inhibitor NSC23766. This inhibitor
impairs the activity of both Tiam1 and TRIO [69]. A
possible explanation is that Tiam1/TRIO might regulate
Rac1 activity during astrocyte migration. The presently
obtained data align with the proposed role for Tiam1
in astrocytes; however, none of the conducted experi-
ments rule out a possible role for TRIO.
Another noteworthy finding of this study was that
PAR-3 binds to Syndecan-4 and regulates FA disassem-
bly in both astrocytes and embryonic fibroblasts. Minor
differences were observed in FA dynamics between cell
types that may be related to their own characteristics:
MEFs basally produce less and smaller FA than astro-
cytes. Consequently, in MEFs lower Nocodazole
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concentrations are required to destabilize the MT net-
work and FA disassembly occurs faster than in astro-
cytes. Similarly, since astrocytes FA are bigger, the effect
of silencing PAR-3 on FA size may tend to make adhe-
sions to overlap, making it difficult to detect differences
in the number of FA. Moreover, PAR-3 localizes to dif-
ferent subcellular compartments, including the leading
edge, FAs, and cell-cell contacts, as well as being more
diffusely distributed in the cytoplasm [18, 51, 62]. PAR-3
localizes to cell-cell contacts in neural crest cells [67],
epithelial cells [25, 64, 66, 67], and fibroblast monolayers
[52, 62, 70]. In neural crest cells (another mesenchymal
cell type), PAR-3 controls contact inhibition of locomo-
tion [67], while in epithelial cells, PAR-3 is required to
establish apico-basal cell polarity [25]. Importantly, the
participation of PAR-3 in FA disassembly is a novel and
previously unappreciated role of this protein in cellular
behavior, one that could explain the activation of Rac1
at the leading edge of cells with polarized migration. In a
wound-healing assay of a neural crest cell monolayer,
contact inhibition of locomotion polarizes cells to the
wounded area. Considering the results presented by
Mayor and co-workers [67], it is plausible to speculate
that the role of PAR-3 differs between cell-cell contact
sites and the leading edge in neural crest cell and other
mesenchymal-like cells, such as fibroblasts and astrocytes.
PAR-3 could bind the Rac1 GEF (i.e. TRIO) in cell-cell
contacts, thereby inhibiting Rac1 through Rac1 GEF se-
questration and, ultimately, polarizing the cells to the
wound. In contrast, PAR-3 at the leading edge would bind
to the Rac1 GEF (i.e. Tiam1) to activate Rac1 and promote
membrane protrusions and polarized cell migration. Dif-
ferent associated partners in each location could account
for varied functions, or the distinct PAR-3 isoforms could
regulate each function. Analysis of these possibilities re-
quires further studies.
Considering that Syndecan-4 regulates FAK autophos-
phorylation, the activation of RhoA and Rac1 GTPases,
lamellipodia formation, and cell adhesion and migration
[8, 17, 43]; additionally that, PAR-3 binds Tiam1 and
FAK [51, 56, 67, 68], together with the present findings
that Syndecan-4 binds PAR-3 and PAR-3 participates in
FA disassembly (which correlates with increased FAK
dephosphorylation and Tiam1 activation), we propose an
integrative, comprehensive model for the role of
Syndecan-4/PAR-3 signaling in FA dynamics (Graphical
Abstract). We postulate that the Syndecan-4/PAR-3 sig-
naling complex recruits Tiam1 and FAK, possibly to
promote FAK dephosphorylation and the localization
and activation of Tiam1 near the plasma membrane.
This model highlights the role of the Syndecan-4/PAR-3
complex and FAK in controlling FA dynamics. At the
membrane, Tiam1 activates Rac1 and is implicated in
cell migration [71], and whether it is also involved in FA
dynamics by virtue of its association with the Syndecan-
4/PAR-3 signaling complex or by binding to PIP3 at the
plasma membrane (Fig. 3c) is yet to be investigated.
Conclusions
In summary, our findings indicate that PAR-3 is a novel
Syndecan-4-binding protein, and that the newly termed
Syndecan-4/PAR-3 signaling complex participates in FA dis-
assembly. Both observations are key findings for understand-
ing the signaling pathways regulating the adhesion and
migration of mesenchymal cells. This novel Syndecan-4/
PAR-3 signaling pathway provides new insights into the sig-
naling mechanisms downstream of Syndecan-4 and the role
PAR-3 plays in polarized cell migration. Due to the import-
ance of syndecans in cytoskeletal regulation, migration, and
cell-cell as well as cell-matrix interactions [36, 72, 73], future
studies addressing the novel Syndecan-4/PAR-3 pathway in
processes such as wound-healing and scarring should be of
major interest in efforts to treat fatal chronic wounds.
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Additional file 1. Precipitation of Syndecan-4 binding Proteins for MS.
(A) Syndecan-4 cytoplasmic tail contains three different regions named
C1-V-C2. The peptides used to precipitate Syndecan-4 binding proteins
contain the last 10 amino acids indicated (SDC4). In control peptides
(CTRL) the last 4 amino acids, EFYA have been replaced to four glycine.
(B) Protein extracts from DI TNC1 cells, stimulated or not (NS) with fetal
bovine serum (FBS), were precipitated with either biotinylated peptides
of the Syndecan-4 (SDC4)-C-terminal sequence, which includes the C2 se-
quence, or the control peptide (CTRL). Precipitates were size-fractionated
by 4–12% SDS-PAGE and silver stained. Bands differentially precipitated
with SDC4 peptides were cut from the gel and analyzed by MS as de-
scribed in Material and Methods. Relative molecular weight (Mr) is indi-
cated to the right in kDa. The symbols (*) and (*’) indicate the bands
identified as PAR-3 and Syntenin, respectively.
Additional file 2. Movie S1. siCTRL+Thy-1-Fc. Time lapse video of Thy-
1-Fc-induced FA disassembly in cells expressing PAR-3. siControl-
transfected DI TNC1 cells were co-transfected with mCherry-vinculin for
48 h and then incubated with 10 μM Nocodazole for 4 h. The Nocodazole
was removed, and the samples were recorded for 30 min during stimula-
tion with Thy-1-Fc.
Additional file 3. Movie S2. siPAR-3+ Thy-1-Fc. Time lapse video of
Thy-1-Fc-induced FA disassembly in cells with decreased PAR-3 levels.
siPAR-3-transfected DI TNC1 cells were co-transfected with mCherry-
vinculin for 48 h and then incubated with 10 μM Nocodazole for 4 h. The
Nocodazole was removed, and the samples were recorded for 30 min
during stimulation with Thy-1-Fc.
Additional file 4. Movie S3. siCTRL+TRAIL-R2-Fc. Time lapse video of
control FA disassembly. siControl-transfected DI TNC1 cells were co-
transfected with mCherry-vinculin for 48 h and then incubated with
10 μM Nocodazole for 4 h. The Nocodazole was removed, and the sam-
ples were recorded for 30 min during treatment with TRAIL-R2-Fc.
Additional file 5. Movie S4. siPAR-3+ TRAIL-R2-Fc. Time lapse video of
control FA disassembly in cells with decreased PAR-3 levels. siPAR-3-
transfected DI TNC1 cells were co-transfected with mCherry-vinculin for
48 h and then incubated with 10 μM Nocodazole for 4 h. The Nocodazole
was removed, and the samples were recorded for 30 min during treat-
ment with TRAIL-R2-Fc.
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